Sep 11, 2026 04:05PM
Jun 29, 2026 08:00AM
May 27, 2026 08:00AM
May 15, 2026 04:05PM
Jan 17, 2026 08:00AM
Nov 20, 2025 08:00PM
Nov 20, 2025 08:00PM NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward
Oct 31, 2025 09:20AM
Oct 30, 2025 11:02PM
Oct 30, 2025 11:02PM
Oct 14, 2025 08:00AM
May 5, 2025 08:00AM
May 1, 2025 08:01AM
May 1, 2025 08:00AM 4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
Mar 27, 2025 08:00AM
Feb 19, 2025 08:00AM
Feb 8, 2025 02:30PM
Jan 29, 2025 08:00AM
Jan 10, 2025 08:07AM
Jan 10, 2025 08:00AM
Sep 19, 2024 08:06AM Chardan Capital Markets Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Jun 8, 2024 04:30PM
Mar 28, 2024 01:32PM
Feb 7, 2024 05:33AM
Feb 7, 2024 05:21AM
Feb 6, 2024 11:27PM
Feb 5, 2024 04:05PM
Feb 5, 2024 04:05PM 4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
Feb 5, 2024 05:44AM
Feb 3, 2024 05:00PM
Jan 29, 2024 08:00AM
Jan 23, 2024 08:07AM
Nov 9, 2023 04:19PM
Oct 30, 2023 08:01AM
Oct 30, 2023 08:00AM 4DMT Gains Alignment with FDA on Plan to Lift Clinical Hold on Phase 1/2 INGLAXA Clinical Trial for 4D-310 for Fabry Disease Cardiomyopathy
Jul 31, 2023 05:41AM
Jul 29, 2023 12:00PM
Jul 10, 2023 07:30PM
Jul 5, 2023 05:35AM
Jun 7, 2023 04:10PM
Jun 7, 2023 04:10PM
Jun 1, 2023 08:00AM 4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
May 11, 2023 08:00AM
May 11, 2023 08:00AM
May 9, 2023 04:05PM
May 8, 2023 04:05PM
May 5, 2023 05:43AM
May 4, 2023 09:04PM
May 4, 2023 04:09PM 4D Molecular Therapeutics Inc. (FDMT) Announces Proposed $100M Share Offering
May 4, 2023 04:08PM

330,737 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All